Pituitary adenoma pathophysiology
Pituitary adenoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Pituitary adenoma pathophysiology On the Web |
American Roentgen Ray Society Images of Pituitary adenoma pathophysiology |
Risk calculators and risk factors for Pituitary adenoma pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ahmad Al Maradni, M.D. [2]
Overview
On gross pathology, a well circumscribed suprasellar mass is a characteristic finding of pituitary adenoma. On microscopic histopathological analysis, a monomorphic expansion of usually one cell type with lack of reticulin network among neoplastic cells is a characteristic finding of pituitary adenoma.
Pathophysiology
- Pathological feature
- The radioanatomical classification places adenomas into 1 of 4 grades:
- Stage I involve microadenomas (<1 cm) without sellar expansion.
- Stage II involve macroadenomas (≥1 cm) and may extend above the sella.
- Stage III involve macroadenomas with enlargement and invasion of the floor or suprasellar extension.
- Stage IV involve macroadenomas that cause destruction of the sella.
- Microadenoma[1]
- Pituitary microadenomas are defined as adenomas less than 10 mm in size.
- Most frequently diagnosed as a result of investigating hormonal imbalance.
- They are confined to the sella and has no scope to produce mass effect related symptoms.
- Macroadenoma[2]
- Pituitary macroadenomas are the most common suprasellar mass in adults.
- They are defined as adenomas greater than 10 mm in size and are most frequently diagnosed due to compression of the surrounding structures, such as optic chiasm.
- Larger adenomas can lead to hormonal imbalance due to mass effect rather than secretion.
- Hypopituitarism or moderately elevated prolactin are both seen, the later due to stalk effect; prolactin release (unlike other pituitary hormones) is tonically inhibited by prolactin inhibitory hormone (a.k.a. dopamine) and as such compression of the pituitary infundibulum can result in elevation of systemic prolactin levels due to interruption of normal inhibition.
- Macroadenomas are approximately twice as common as micoadenoma.
References
- ↑ pituitary micro adenoma Dr Amir Rezaee and Dr Frank Gaillard. 2015 http://radiopaedia.org/articles/pituitary-microadenoma
- ↑ Pituitary adenoma. Dr Amir Rezaee and Dr Yuranga Weerakkody. Radiopaedia.org 2015.http://radiopaedia.org/articles/pituitary-adenoma